Clinical trial
SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma
NCT01445392
Study timeline
Study start (unknown)2007-11-14Date precision: day
Registry last updated2018-08-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Mesotheliomaunresolved
Interventions
Multicycle SS1PBIOLOGICAL
PemetrexedDRUG · verified · RxNorm: pemetrexed
CisplatinDRUG · verified · RxNorm: cisplatin
Single cycle SS1PBIOLOGICAL
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01445392 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.